Showing 66,221 - 66,240 results of 102,731 for search '(( e point decrease ) OR ( 5 ((((nn decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.96s Refine Results
  1. 66221

    Secondary metabolites from <i>Gentiana cruciata</i> L. and their anti-inflammatory and analgesic activities by Rima Konya (14075753)

    Published 2023
    “…<p>A previously unreported secoiridoid glycoside, cruciatoside (<b>1</b>) was isolated from the aerial parts of <i>Gentiana cruciata</i> L. along with ten known compounds eustomoside (<b>2</b>), eustomorusside (<b>3</b>), gentiopicroside (<b>4</b>), 6'-<i>O</i>-β-D-glucopyranosyl gentiopicroside (<b>5</b>), loganic acid (<b>6</b>), isoorientin (<b>7</b>), isovitexin (<b>8</b>), isovitexin 2''<i>-(E)-</i>ferulate (<b>9</b>), mangiferin (<b>10</b>), and 2-methyl-inositol (<b>11</b>). …”
  2. 66222

    MPs<sup>PPARα+/+</sup>-induced EPC differentiation and <i>in vitro</i> angiogenesis of mature ECs involve NF-κB pathway activation. by Tarek Benameur (196206)

    Published 2010
    “…<p>(<b>A</b>) Western blot showing that MPs<sup>PPARα+/+</sup> induced I-κB phosphorylation on activator sites (Ser32/36) in EPCs, indicating that NF-κB pathway is activated. …”
  3. 66223

    Evolutionary dynamics of iPD-population consisting of two types of players: With WSLS and AllD strategies. by Anton M. Unakafov (5706560)

    Published 2020
    “…<p>(A) Initially, both types have the same frequency, but after 40 generations the fraction of WSLS-players <i>x</i><sub>1</sub>(<i>t</i>) converges to 0 for probabilities to see partner’s choice <i>p</i><sub>see</sub> = 0.0, 0.2 and to 1 for <i>p</i><sub>see</sub> = 0.4, 0.5. …”
  4. 66224

    Altered TRPV1 staining is observed in DRG obtained from STZ-induced diabetic mice by Reddy M Pabbidi (44094)

    Published 2011
    “…Summary graph showing increase in mean gray values of TRPV1 staining (n = 5 sections from 4 mice, p < 0.058) in hyperalgesic DRG and decrease in TRPV1 gray value in hypoalgesic diabetic mice (n = 6 sections from 4 mice, p < 0.05) as compared to control non-diabetic mice. . …”
  5. 66225

    Chemical composition and antioxidant capacity of coffee pulp by Graciela Munguía Ameca (5671427)

    Published 2018
    “…Ensiling and sun drying did not decrease (P>0.05) caffeine or tannins. No differences were found in caffeic acid (2.031±2.873, 5.103±0.391, 4.913±0.018 mg g-1 DM in FCP, ECP, EDCP, respectively). …”
  6. 66226

    Effect of Vitrification on the MicroRNA Transcriptome in Mouse Blastocysts by Xueming Zhao (400630)

    Published 2015
    “…Of these, the expression levels of five miRNAs differed significantly: in the vitrified blastocysts, four miRNAs (mmu-miR-199a-5p, mmu-miR-329-3p, mmu-miR-136-5p and mmu-miR-16-1-3p) were upregulated, and one (mmu-miR-212-3p) was downregulated. …”
  7. 66227

    FDG PET parameters and survival curves. by Julien Ganem (7490378)

    Published 2019
    “…<p>Survival curves using the Kaplan-Meier method. <b>(a)</b> PFS was longer for patients with low TLG<sub>2</sub> (HR = 2.8, 95%CI 1.3–5.9, p< 0.01). …”
  8. 66228

    Germination of fungal pathogen spores in calcium, copper, manganese and zinc chelated with aminoacids by Eloisa Lorenzetti (5021009)

    Published 2021
    “…For the second assay, the same pathogens had a mean reduction of 52%, 59%, 77%, 87%, 81% and 64% for P. sorghi and 40%, 33%, 17%, 18%, 4% and 2% for Cercospora sp., both at zero, 1, 2, 3, 4 and 5 hours after treatment, respectively. …”
  9. 66229

    Loss of FHL2 reduces intestinal polyp multiplicity. by Charlotte Labalette (365229)

    Published 2013
    “…<p>(A) Representative images of intestines from 11-month-old <i>Apc<sup>Δ14/+</sup>FHL2<sup>+/+</sup></i> and <i>Apc<sup>Δ14/+</sup>FHL2<sup>−/−</sup></i> mouse. …”
  10. 66230

    SF-E inhibits NMDA-induced ROS production without altering cell viability of primary cortical neurons. by Jinghua Jiang (527159)

    Published 2014
    “…<p>(A) Exposure of SF-E (0–7.5 µg/mL) to primary cortical neurons for 24 h did not alter neuronal viability as assayed by MTT. …”
  11. 66231

    Image_2_Culex quinquefasciatus Late Trypsin Biosynthesis Is Translationally Regulated by Trypsin Modulating Oostatic Factor.TIF by Dov Borovsky (8892182)

    Published 2021
    “…However, Northern blot analysis showed that TMOF injections did not cause a decrease in trypsin transcript abundance, indicating that TMOF probably affected trypsin translation.…”
  12. 66232

    Image_1_Culex quinquefasciatus Late Trypsin Biosynthesis Is Translationally Regulated by Trypsin Modulating Oostatic Factor.TIF by Dov Borovsky (8892182)

    Published 2021
    “…However, Northern blot analysis showed that TMOF injections did not cause a decrease in trypsin transcript abundance, indicating that TMOF probably affected trypsin translation.…”
  13. 66233

    Image_3_Culex quinquefasciatus Late Trypsin Biosynthesis Is Translationally Regulated by Trypsin Modulating Oostatic Factor.TIF by Dov Borovsky (8892182)

    Published 2021
    “…However, Northern blot analysis showed that TMOF injections did not cause a decrease in trypsin transcript abundance, indicating that TMOF probably affected trypsin translation.…”
  14. 66234

    Bacteria modify the shoot Pi content in the plant. by Sur Herrera Paredes (674875)

    Published 2018
    “…(D) Colonization capacity of 6 bacterial strains selected according to their performance in binary-association assays: 3 strains increased (green arrows) and another 3 decreased (red arrows) the shoot Pi content (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2003962#pbio.2003962.s003" target="_blank">S3E Fig</a>). …”
  15. 66235

    Methylation profiling in control and Tet tcKO retinas. Related to Fig 6. by Ismael Hernández-Núñez (10128242)

    Published 2025
    “…<p><b>(A)</b> Graphic displaying results of WGBS and bACE-seq to distinguish 5mC and 5hmC marks. …”
  16. 66236

    Data_Sheet_6_Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health.PDF by María D. Ferrer (8722935)

    Published 2020
    “…Fifty nine volunteers were enrolled in the study and randomly assigned to a treatment or placebo group. The treatment consisted of a bucco-adhesive gel application (2.5 10<sup>9</sup> cfu/dose) with a dental splint for 5 min every 48 h, for a period of 1 month (i.e., 14 doses). …”
  17. 66237

    Data_Sheet_4_Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health.PDF by María D. Ferrer (8722935)

    Published 2020
    “…Fifty nine volunteers were enrolled in the study and randomly assigned to a treatment or placebo group. The treatment consisted of a bucco-adhesive gel application (2.5 10<sup>9</sup> cfu/dose) with a dental splint for 5 min every 48 h, for a period of 1 month (i.e., 14 doses). …”
  18. 66238

    Data_Sheet_2_Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health.PDF by María D. Ferrer (8722935)

    Published 2020
    “…Fifty nine volunteers were enrolled in the study and randomly assigned to a treatment or placebo group. The treatment consisted of a bucco-adhesive gel application (2.5 10<sup>9</sup> cfu/dose) with a dental splint for 5 min every 48 h, for a period of 1 month (i.e., 14 doses). …”
  19. 66239

    NIR fluorescence lifetime FRET of TfnR-Tfn complexes in normal vs. cancer cells using time-domain, wide-field macroscopic imaging <i>in vitro.</i> by Ken Abe (488464)

    Published 2013
    “…(D) Sensitivity of FD% is consistent across 1×10<sup>5</sup> to 1×10<sup>4</sup> cells (Table S6 in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0080269#pone.0080269.s001" target="_blank">File S1</a>). …”
  20. 66240

    Data_Sheet_7_Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health.PDF by María D. Ferrer (8722935)

    Published 2020
    “…Fifty nine volunteers were enrolled in the study and randomly assigned to a treatment or placebo group. The treatment consisted of a bucco-adhesive gel application (2.5 10<sup>9</sup> cfu/dose) with a dental splint for 5 min every 48 h, for a period of 1 month (i.e., 14 doses). …”